Enlonstobart

DRUG2 trials

Sponsors

Shanghai JMT-Bio Inc.

Conditions

HER2-positive Gastric Cancer

Phase 2

JSKN003 Combined Treatment of HER2-positive Gastric Cancer

Not yet recruitingNCT06998771

Shanghai JMT-Bio Inc.HER2-positive Gastric Cancer

Start: 2025-06-15End: 2029-12-31Target: 153Updated: 2025-05-31

A Study of KN026-based Combination Therapy in HER2-positive Gastric Cancer

Not yet recruitingNCT07332533

Shanghai JMT-Bio Inc.HER2-positive Gastric Cancer

Start: 2025-12-30End: 2032-12-31Target: 490Updated: 2026-01-12